Quick Answer
BetterLife Pharma Inc. reported Diluted EPS of $0.11 per share (loss) for fiscal year 2016.
BetterLife Pharma Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2016 | -$0.11 | -10.0% |
| 2015 | -$0.10 | +50.0% |
| 2014 | -$0.20 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| April 30, 2019 | -$0.02 | +33.3% | +50.0% |
| October 31, 2018 | -$0.04 | -500.0% | -33.3% |
| April 30, 2018 | -$0.03 | — | -400.0% |
| October 31, 2017 | $0.01 | +200.0% | +200.0% |
| October 31, 2016 | -$0.01 | — | +75.0% |
| April 30, 2016 | -$0.04 | -100.0% | — |
| October 31, 2015 | $0.00 | — | +100.0% |
| July 31, 2015 | -$0.04 | — | -100.0% |
- BetterLife Pharma Inc. showed a decrease of -10.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2014–2016 period, BetterLife Pharma Inc.’s diluted eps has grown by 45.0% (from $0.20 per share (loss) to $0.11 per share (loss)).
- The most recent figure is from BetterLife Pharma Inc.’s fiscal year 2015 report (Form 10-K), filed with the SEC on April 29, 2016.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: